Ameritas Investment Partners’s Ovid Therapeutics OVID Stock Holding History

Ameritas Investment Partners’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.4K	Buy	+13,896	New	+$35.9K	﹤0.01%	2430
2025 Q2	–	Sell	-4,924	Closed	-$1.54K	–	3304
2025 Q1	$1.54K	Hold	4,924	–	–	﹤0.01%	3086
2024 Q4	$4.6K	Hold	4,924	–	–	﹤0.01%	3038
2024 Q3	$5.81K	Hold	4,924	–	–	﹤0.01%	3022
2024 Q2	$3.79K	Hold	4,924	–	–	﹤0.01%	3058
2024 Q1	$15K	Hold	4,924	–	–	﹤0.01%	2676
2023 Q4	$15.9K	Hold	4,924	–	–	﹤0.01%	2689
2023 Q3	$18.9K	Hold	4,924	–	–	﹤0.01%	2566
2023 Q2	$16.2K	Buy	+4,924	New	+$16.7K	﹤0.01%	2674
2021 Q2	–	Sell	-3,782	Closed	-$15K	–	3183
2021 Q1	$15K	Hold	3,782	–	–	﹤0.01%	2683
2020 Q4	$9K	Hold	3,782	–	–	﹤0.01%	2833
2020 Q3	$22K	Hold	3,782	–	–	﹤0.01%	2327
2020 Q2	$28K	Buy	+3,782	New	+$17.7K	﹤0.01%	2168
2019 Q2	–	Sell	-443	Closed	-$1K	–	3095
2019 Q1	$1K	Hold	443	–	–	﹤0.01%	2966
2018 Q4	$1K	Hold	443	–	–	﹤0.01%	2981
2018 Q3	$3K	Hold	443	–	–	﹤0.01%	2993
2018 Q2	$3K	Hold	443	–	–	﹤0.01%	2972
2018 Q1	$3K	Hold	443	–	–	﹤0.01%	2907
2017 Q4	$4K	Hold	443	–	–	﹤0.01%	2895
2017 Q3	$4K	Hold	443	–	–	﹤0.01%	2940
2017 Q2	$5K	Buy	+443	New	+$5.78K	﹤0.01%	2933

Other funds holding OVID

Jupiter Topco New York $245B AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Ameritas Investment Partners's OVID Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 13,896 shares worth $37.4K. The stake represents ﹤0.01% of the portfolio and ranks #2430 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in OVID as recently as Q1 2025.

Ameritas Investment Partners first reported a position in OVID in Q2 2017 and has held it in 21 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

Ameritas Investment Partners held 13,896 shares of Ovid Therapeutics worth $37.4K as of Q2 2026.
Ovid Therapeutics was a new Ameritas Investment Partners position in Q2 2026.
Ovid Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2430 holding.
Ameritas Investment Partners first reported a position in Ovid Therapeutics in Q2 2017 and has held it in 21 quarters since.
130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.